［1］Hirsch FR，Mcelhinny A，Stanforth D，et al.PD-L1 immunohistochemistry assays for lung cancer：results from phase 1 of the blueprint PD-L1 IHC assay comparison project［J］.Journal of Thoracic Oncology：Official Publication of the International Association for the Study of Lung Cancer，2017，12(2)：208.
［2］Shen Y，Wu B，Wang X，et al.Health state utilities in patients with advanced non-small-cell lung cancer in China［J］.J Comp Eff Res，2018，7(5)：443-452.
［3］CHEN WJ，LI GF.Advances in molecular targeted therapy for non-small cell lung cancer［J］.Modern Oncology，2017，25(12)：1994-1996.［陈文杰，李高峰.非小细胞肺癌的分子靶向治疗研究进展［J］.现代肿瘤医学，2017，25(12)：1994-1996.］
［4］Kishida S，Kato-Mori Y，Hagiwara K.Influence of changes in the intestinal microflora on the immune function in mice［J］.Journal of Veterinary Medical Science，2018，80(3)：440-446.
［5］Li X，Wang H，Du X，et al.Lactobacilli inhibit cervical cancer cell migration in vitro and reduce tumor burden in vivo through upregulation of E-cadherin［J］.Oncology Reports，2017，38(3)：1561-1568.
［6］Suzuki T，Masui A，Nakamura J，et al.Yogurt containing lactobacillus gasseri mitigates aspirin-induced small bowel injuries：A prospective，randomized，double-blind，placebo-controlled trial［J］.Digestion，2017，95(1)：49-54.
［7］SHEN X，LI M，SHI L，et al.Studies on immunomodulation and antiallergic effects of lactobacillus［J］.Journal of Sichuan University(Medical Edition)，2016，47(2)：192-196.［沈曦，李鸣，石磊，等.乳酸杆菌的免疫调节及抗过敏作用研究［J］.四川大学学报(医学版)，2016，47(2)：192-196.］
［8］Jansen GJ.The influence of oral treatment with enterococcus faecalis on the human gut microflora and on the systemic humoral immune response［J］.Journal of the Pakistan Medical Association，2016，52(10)：459-465.
［9］Zhang J，Chen SL，Li LB.Correlation between intestinal flora and serum inflammatory factors in patients with Crohn’s disease［J］.Eur Rev Med Pharmacol Sci，2017，21(21)：4913-4917.
［10］Kuno T，Hirayamakurogi M，Ito S，et al.Effect of intestinal flora on protein expression of drug-metabolizing enzymes and transporters in liver and kidney of germ-free and antibiotics-treated mice［J］.Molecular Pharmaceutics，2016，13(8)：2691.
［11］HUANG Y，WU HY.Intestinal flora and antitumor therapy［J］.Chinese Journal of Immunology，2016，32(12)：1859-1861.［黄亚，吴红艳.肠道菌群与抗肿瘤治疗［J］.中国免疫学杂志，2016，32(12)：1859-1861.］
［12］Alderton GK.Tumour immunology：Intestinal bacteria are in command［J］.Nature Reviews Cancer，2016，16(1)：4.
［13］REN X，YANG XJ，XIONG Q.Research progress on the relationship between intestinal flora disorder and insulin resistance and its mechanism［J］.Shandong Medicine，2017，57(24)：103-105.［任汐，杨学军，熊青.肠道菌群失调与胰岛素抵抗关系及作用机制的研究进展［J］.山东医药，2017，57(24)：103-105.］
［14］Sartor RB.Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease［J］.Canadian Journal of Gastroenterology，2016，4(7)：271-277.
［15］Poutahidis T，Cappelle K，Levkovich T，et al.Pathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice［J］.Plos One，2013，8(8)：e73933.
［16］Lakritz JR，Poutahidis T，Levkovich T，et al.Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice［J］.International Journal of Cancer，2014，135(3)：529.